Poster (Scientific congresses and symposiums)
A phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic cervical cancer : updated analysis of full cervical expansion cohort
Concin, Nicole; Vergote, Ignace; Lassen, Ulrik Niels et al.
2018ESMO Congress 2018
 

Files


Full Text
A phase IIa study of Tisotumab Vedotin in patients ... poster CG.pdf
Publisher postprint (1.38 MB)
Request a copy
Annexes
A phase IIa study of Tisotumab Vedotin in patients ... abstract CG.pdf
Publisher postprint (82.64 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
oncology; tisotumab; metastatic cervical cancer
Disciplines :
Oncology
Author, co-author :
Concin, Nicole;  Leuven Cancer Institute
Vergote, Ignace;  Leuven Cancer Institute
Lassen, Ulrik Niels
Drew, Yvette
Machiels, Jean-Pascal
Arkenau, Hendrik-Tobias
Forster, Martin David
Jones, Robert
Johnson, Melissa Lynne
Slomovitz, Brian M
Spicer, James F.
Cornez, Nathalie
GENNIGENS, Christine  ;  Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale
Coleman, Robert L
Windfeld, Kristian
Ghatta, Srinivas
Rangwala, Reshma A.
Hong, David S.
More authors (8 more) Less
Language :
English
Title :
A phase IIa study of tisotumab vedotin in patients with previously treated recurrent or metastatic cervical cancer : updated analysis of full cervical expansion cohort
Publication date :
20 October 2018
Event name :
ESMO Congress 2018
Event place :
Munich, Germany
Event date :
19-23 October 2018
Audience :
International
Available on ORBi :
since 12 December 2019

Statistics


Number of views
42 (4 by ULiège)
Number of downloads
6 (6 by ULiège)

Bibliography


Similar publications



Contact ORBi